Why Health Canada’s Recent Announcement Could Be Bad News for Canopy Growth (TSX:WEED)

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has long been the industry leader in Canada, but will more competition put that in jeopardy?

| More on:
Person Hands Opening Mailbox To Remove Newspaper

Image source: Getty Images

We could be seeing a lot more competition in the cannabis industry very soon.

Health Canada recently announced that it would be making it easier for companies to obtain cannabis licenses. Previously, applicants didn’t have to have their sites ready to go before submitting their applications, which has created a lot of back-and-forth that wasn’t necessary that the government felt resulted in a lot of inefficiencies and bottlenecks along the way.

With a supply shortage of cannabis in Canada, there’s definitely an incentive to expedite the process. By requiring applicants to have a site already built and in compliance with regulations right at the start, it will help streamline the process and ensure that time isn’t being wasted on applicants that still have a long ways to go.

More competition could be bad news for industry leaders

While a company like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) might be enjoying its place atop the industry today, more competition will make it more difficult for the company to keeps its advantage and strong market share. With advertising in the industry being limited, there’s not much of an advantage Canopy Growth can have over its rivals, especially in Ontario, where restrictions around store ownership mean it will have limited say in the retail side of things.

And with an increase in competition, that will help drive down prices and give consumers more options to choose from. Both of those consequences will have a negative impact on Canopy Growth’s financials, which aren’t all that strong to begin with. While some of the more promising competitors have been acquired by Canopy Growth and other big cannabis companies, further acquisitions will require cash being spent or a company having to issue new shares, resulting in dilution for existing shareholders.

Industry leaders don’t want to see too much competition, as it will result in more effort being needed to win market share by driving costs and prices down as much as possible. Although Canopy Growth has managed to turn a profit in two of its past five quarters, operationally it has been nowhere near break even as it has been other income that has been able to land the company into the black.

Bottom line

For consumers, the news from Health Canada is a big win. By getting more growers and producers out there, it’ll help the industry meet demand and hopefully keep more customers from having to go to the black market. However, with the possibility for even more fragmentation in an industry that already has lot of small companies vying for market share, it’s going to make it more difficult for a single company to dominate the market.

The key will lie in acquisitions, and that’s where having a strong balance sheet and lots of cash on hand is going to be paramount to staying near the top of the industry. For Canopy Growth, that could be a problem, especially with the company focusing on the U.S. market lately.


This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »